venBio Global Strategic GP II, L.P.

10% owner at Checkmate Pharmaceuticals, Inc.; 10% owner at AKRO

Sold, on record
$1.8M
Dollars the filings state
Form 4 sales
3
Latest Apr 26, 2022
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale AKROPlan not stated
    Feb 12 2020

    Sold 10,026 shares at $27.07 ($271k)

    venBio Global Strategic GP II, L.P., 10% owner

    Sold 0.3% of holdings ($87.8M position)3.2M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale AKROPlan not stated
    Feb 27 +15 days

    Sold 5,904 shares at $22.80 ($135k)

    venBio Global Strategic GP II, L.P., 10% owner

    Sold 0.2% of holdings ($73.7M position)3.2M shares leftFiling

  3. 3 Form 4 sale Checkmate Pharmaceuticals, Inc.Plan not stated
    Apr 26 +789 days

    Sold 129,781 shares at $10.39 ($1.3M)

    venBio Global Strategic GP II, L.P., 10% owner

    Sold 4.2% of holdings ($32.5M position)3M shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by venBio Global Strategic GP II, L.P.
Source
Apr 26, 2022Checkmate Pharmaceuticals, Inc.10% ownerForm 4 sale129,781$1.3M4.2%Plan not statedSEC
Feb 27, 2020AKRO10% ownerForm 4 sale5,904$135k0.2%Plan not statedSEC
Feb 12, 2020AKRO10% ownerForm 4 sale10,026$271k0.3%Plan not statedSEC